Abstract

TNF receptor superfamily members (TNFRSF) such as CD40, Fas and TRAIL receptor 2 (TRAILR2) participate to the adaptive immune response by eliciting survival, proliferation, differentiation and/or cell death signals. The balance between these signals determines the fate of the immune response. It was previously reported that these receptors are able to self-assemble in the absence of ligand through their extracellular regions. However, the role of this oligomerization is not well understood, and none of the proposed hypotheses take into account potential hetero-association of receptors. Using CD40 as bait in a flow cytometry Förster resonance energy transfer assay, TNFRSF members with known functions in B cells were probed for interactions. Both Fas and TRAILR2 associated with CD40. Immunoprecipitation experiments confirmed the interaction of CD40 with Fas at the endogenous levels in a BJAB B-cell lymphoma cell line deficient for TRAILR2. TRAILR2-expressing BJAB cells displayed a robust CD40–TRAILR2 interaction at the expense of the CD40–Fas interaction. The same results were obtained by proximity ligation assay, using TRAILR2-positive and -negative BJAB cells and primary human B cells. Expression of the extracellular domains of Fas or TRAILR2 with a glycolipid membrane anchor specifically reduced the intrinsic signalling pathway of CD40 in 293T cells. Conversely, BJAB cells lacking endogenous Fas or TRAILR2 showed an increased NF-κB response to CD40L. Finally, upregulation of TRAILR2 in primary human B cells correlated with reduced NF-κB activation and reduced proliferation in response to CD40L. Altogether, these data reveal that selective interactions between different TNFRSF members may modulate ligand-induced responses upstream signalling events.

Highlights

  • Germinal centres (GCs) are unique sites in peripheral lymphoid tissue where clonal selection of B-lymphocytes takes place in response to antigen stimulation

  • We tested the ability of CD40 to interact with other TNFRSF members important for B-cell function such as Fas, TRAIL receptor 1 (TRAILR1), TRAILR2, BCMA (TNFRSF17), BAFFR (BR3 or TNFRSF13C), TACI (TNFRSF13B) and the two unrelated receptors ErbB1 and ErbB2

  • Ligand-independent associations of CD40 with itself, with Fas and with TRAILR2 were readily observed with constructs lacking the intracellular domain (ΔICD), indicating that the latter is not required for the observed homo- and heterooligomerizations (Figure 1c)

Read more

Summary

Introduction

Germinal centres (GCs) are unique sites in peripheral lymphoid tissue where clonal selection of B-lymphocytes takes place in response to antigen stimulation. Fas or TRAILR-mediated apoptosis is controlled or counterbalanced in GC cells by another TNFR superfamily member CD40 (TNFRSF5).[10,11,12,13] It is conventionally accepted that CD40-induced protection against Fas or TRAILRmediated apoptosis required NF-κB activation and upregulation of anti-apoptotic c-FLIP and Bcl-XL proteins.[12,14,15,16] Benson et al.[17] described a rapid CD40-mediated rescue from Fas-induced apoptosis that did not require NF-κB activation, was independent of de novo protein synthesis but was dependent upon active PI3K Both previously described rescue mechanisms are ligand dependent, raising the Received 26.10.16; revised 23.12.16; accepted 28.12.16; Edited by G Raschella'. Heteromer formation between receptors with opposite functions could represent the most apical regulation of TNFRSF signalling

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.